REG - Craneware plc - Reduction of Capital confirmed

CranewareAnnouncement

Today 15:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251106:nRSF5528Ga&default-theme=true

RNS Number : 5528G  Craneware plc  06 November 2025

 

Craneware plc

 

("Craneware" or the "Company" or the "Group")

 

Reduction of Capital confirmed

 

 

6 November 2025 - Craneware (AIM: CRW.L), a leader in healthcare financial
performance solutions, announces that the Reduction of Capital, comprising the
Share Premium Reduction and the Merger Reserve Reduction approved by
shareholders at the General Meeting held on 20 August 2025, has today been
confirmed by the Court of Session, Edinburgh, Scotland (the "Court").

 

The Court order will now be registered with the Registrar of Companies, on
registration of which the Reduction of Capital will become effective.

 

The Reduction of Capital will create additional distributable reserves of US$
284,185,184.18. The Reduction of Capital itself does not involve any
distribution or repayment of capital, share premium or merger reserve by the
Company and does not reduce the underlying net assets of the Company.

 

Any terms used but not defined in this announcement are as defined in the
announcement issued by Craneware on 1 August 2025.

 

For further information, please contact:

 

 

Craneware plc
                                              +44
(0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO

 

Alma Strategic
Communications
+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters
                        craneware@almastrategic.com

Peel Hunt (NOMAD and Joint Broker)
 
+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne

Investec Bank PLC (Joint
Broker)
+44 (0)20 7597 5970

Patrick Robb, Virginia Bull, James Smith

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Patrick Dologhan

About Craneware

For over 25 years, The Craneware Group (AIM:CRW.L) has been a leader in
healthcare financial and operational transformation, delivering cutting-edge
technologies that drive measurable impact. Our Trisus(®) cloud ecosystem
unifies data, revenue intelligence, margin intelligence, and advanced
analytics, enabling healthcare organizations to optimize performance, improve
financial sustainability, and drive strategic growth. As a trusted Microsoft
partner, we provide future-ready solutions-including the Best in KLAS Trisus
Chargemaster - that simplify the complexities of healthcare finance and
operations. What sets us apart is our unique combination of deep healthcare
expertise and engineering excellence, positioning us as a strategic partner
rather than just a technology provider. The Craneware Group empowers
healthcare organizations to achieve sustainable financial success while
delivering better outcomes for the communities they serve - today and in the
future. Together, we are transforming the business of healthcare.

 

Learn more at www.thecranewaregroup.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFSUFIMEISEDF



            Copyright 2019 Regulatory News Service, all rights reserved